Qualitative Assessment of the Brief Contact Intervention "Stay in Contact" in Suicide Prevention (EVAREST2)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03325478 |
Recruitment Status :
Completed
First Posted : October 30, 2017
Last Update Posted : October 30, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background: For 40 years, brief contact interventions (BCIs) have been presented as promising approaches in suicide prevention but patient's experiences of BCIs are less investigated.
Aim: Understand mechanisms of BCIs after suicide attempt, through patient's experience of a French BCI "Stay in contact" and assess its impact on seeking care during suicidal crisis.
Method:This is a single-center, non-interventional, prospective qualitative study using phone call interview on a BCI, 6 months after suicide attempt behavior.
Statistical analysis
Data were analyzed using statistical software (Version 9.4, SAS Institute Inc., Cary, North Carolina, USA). Chi-squared test was used to assess qualitative variables and t-test to evaluate quantitative variables, with p<.05 considered significant.
Condition or disease | Intervention/treatment |
---|---|
Suicide and Self-harm | Other: Over the phone interviews on the BCI "Stay in Contact" |
Study Type : | Observational |
Actual Enrollment : | 60 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Official Title: | Qualitative Assessment of the French Brief Contact Intervention "Stay in Contact" in Suicide Prevention |
Actual Study Start Date : | May 18, 2017 |
Actual Primary Completion Date : | August 31, 2017 |
Actual Study Completion Date : | August 31, 2017 |
- Other: Over the phone interviews on the BCI "Stay in Contact"
This study used phone call interviews on a BCI "Stay in Contact", 6 months after suicide attempt behavior.The questionnaire used for the interview of included suicide attempters was pilot tested to assess acceptability and feasibility of the study. It included 24 questions, which were based on literature's data.They covered seeking care and help items and assess the subjective quality appreciation of medical care in the PED and on the BCI.Closed-ended and multiple-choice questions were mixed. Included patients were informed that the questionnaire was anonymous and that seeking their views and feedbacks would help adjusting the implementation of follow-up interventions closer to their needs.The baseline interviews were conducted on the phone, on weekdays, during a mean time of 10 to 15minutes by a trained resident in psychiatry as the only interviewer.
- outpatients' experiences of the BCI "Stay in contact" [ Time Frame: At the closure of the BCI Stay in contact, an average of 6 months after suicide attempt ]to assess the outpatients' experiences of the BCI "Stay in contact" using an hetero questionnaire completed over the phone by patients who benefited from the BCI.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- be male or female, be aged 18 or older, have a situation permitting follow-up contacts by phone.
Exclusion Criteria:
- be placed under supervision by the law such as guardianship and curatorship, be incarcerated and refusing to participate to the BCI

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03325478
France | |
Central Hospital | |
Nancy, Lorraine, France, 54100 |
Principal Investigator: | Catherine Pichene | Psychiatric Emergency Departement, Central Hospital, Nancy, France | |
Principal Investigator: | Fabienne Ligier | Psychiatric Emergency Departement, Central Hospital, Nancy, France | |
Principal Investigator: | Sondos Abdalla | Psychiatric Emergency Departement, Central Hospital, Nancy, France |
Other Publications:
Responsible Party: | Central Hospital, Nancy, France |
ClinicalTrials.gov Identifier: | NCT03325478 |
Other Study ID Numbers: |
2017-A01023-50 |
First Posted: | October 30, 2017 Key Record Dates |
Last Update Posted: | October 30, 2017 |
Last Verified: | August 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Suicide Self-Injurious Behavior Behavioral Symptoms |